Tidepath Get an early invite

Compared, from the FDA labels

Wegovy vs Zepbound

Wegovy (semaglutide) acts on one hormone receptor, GLP-1; Zepbound (tirzepatide) acts on two, GIP and GLP-1. Both are approved for weight. In a 72-week head-to-head trial, people on tirzepatide lost 20.2% of their weight on average and people on semaglutide 13.7%.

Side by side

WegovyZepbound
Medicine in itSemaglutideTirzepatide
Made byNovo NordiskEli Lilly
Receptors it acts onOne: the GLP-1 receptorTwo: the GIP and GLP-1 receptors
Approved forWeight: losing excess weight and keeping it off, for adults and children 12 and older with obesity, and adults with overweight and a weight-related condition. Also lowering the risk of heart attack, stroke or cardiovascular death in adults with heart disease, and (the injection) a liver disease, MASH, with moderate to advanced scarringWeight: losing excess weight and keeping it off, for adults with obesity, or overweight with a weight-related condition. Also moderate to severe obstructive sleep apnea in adults with obesity
How it's takenAn injection once a week, or a tablet once a dayAn injection once a week
Starting doseInjection: 0.25 mg a week for 4 weeks. Tablet: 1.5 mg a day for 30 days2.5 mg a week for 4 weeks, then 5 mg
Dose it builds up toUsually 2.4 mg a week (injection), or 25 mg a day (tablets)5 mg, 10 mg or 15 mg a week for weight; 10 or 15 mg for sleep apnea
Half-lifeAbout 1 weekAbout 5 to 6 days
If you miss a doseInjection: goes by your next dose. More than 2 days away, take it; less, skip itTake it within 4 days (96 hours); after that, skip it

Both are weekly injections approved for weight, and both carry the same boxed warning about thyroid tumors seen in animal studies. Wegovy also comes as a daily tablet.

Doses are what each label sets out. Your prescriber decides yours.

In head-to-head trials

These trials gave people one medicine or the other and compared them directly.

SURMOUNT-5

In SURMOUNT-5, published in the New England Journal of Medicine in 2025, 751 adults with obesity but without type 2 diabetes took the highest dose they could tolerate of tirzepatide (10 or 15 mg, the medicine in Zepbound) or semaglutide (1.7 or 2.4 mg, the medicine in Wegovy), once a week for 72 weeks.

Weight fell by an average of 20.2% on tirzepatide and 13.7% on semaglutide. Waist size fell by 18.4 cm and 13.0 cm.

The most common side effects in both groups were stomach-related, mostly mild to moderate, and mostly while the dose was being raised.

Everyone knew which medicine they were taking (an open-label trial), and the trial was funded by Eli Lilly, which makes tirzepatide.

Questions about Wegovy and Zepbound

What's the difference between Wegovy and Zepbound?

Wegovy (semaglutide) acts on one hormone receptor, GLP-1; Zepbound (tirzepatide) acts on two, GIP and GLP-1. Both are approved for weight. In a 72-week head-to-head trial, people on tirzepatide lost 20.2% of their weight on average and people on semaglutide 13.7%.

More detail and sources

Both are weekly injections approved for weight, and both carry the same boxed warning about thyroid tumors seen in animal studies. Wegovy also comes as a daily tablet.

Is Zepbound better than Wegovy for weight loss?

In a head-to-head trial, people on tirzepatide (the medicine in Zepbound) lost more weight. Weight fell by an average of 20.2% on tirzepatide and 13.7% on semaglutide. Waist size fell by 18.4 cm and 13.0 cm.

More detail and sources

In SURMOUNT-5, published in the New England Journal of Medicine in 2025, 751 adults with obesity but without type 2 diabetes took the highest dose they could tolerate of tirzepatide (10 or 15 mg, the medicine in Zepbound) or semaglutide (1.7 or 2.4 mg, the medicine in Wegovy), once a week for 72 weeks.

Which one suits you depends on your health, your other medicines and your coverage, and is a decision for you and your prescriber.

Are Wegovy and Zepbound the same drug?

No. Wegovy contains semaglutide, made by Novo Nordisk; Zepbound contains tirzepatide, made by Eli Lilly.

Can I switch from Wegovy to Zepbound?

Only with your prescriber. None of the four labels gives a dose for switching from one of these brands to another, so your prescriber chooses where the new medicine starts.

More detail and sources

Don't take them together. Wegovy's and Zepbound's labels say they're not recommended with any other GLP-1 medicine.

Do Wegovy and Zepbound have the same side effects?

Their most common side effects are similar and mostly stomach-related, such as nausea, diarrhea, vomiting and constipation. Each label lists its own, from its own trials.

More detail and sources

See what each label says: Wegovy side effects, Zepbound side effects.

Sources

Last reviewed

For information, not medical advice. Your prescriber and your product's label come first.

Keep your shots, food and training in one place.

Tidepath is an iPhone app for people on a GLP-1, whichever one you take. It isn't in the App Store yet. Leave your email for an early invite, and tips for your first month. See how the app works